Sequenom’s ‘incorporeal’ prenatal genetic test unpatentable, Ariosa tells Full Court

Intellectual Property 2020-06-29 9:12 pm By Miklos Bolza | Sydney

Ariosa Diagnostics is fighting to revoke a patent for noninvasive prenatal test owned by Sequenom, arguing it merely describes how to extract “incorporeal” genetic information that is naturally found within the DNA of an unborn foetus.